Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas D Ross

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|January 18, 2012
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceKarthika Natarajan, Yi Xie, Maria R Baer, et al.
Statistics in Medicine|January 12, 2008
Experimental design and interaction analysis of combination studies of drugs with log-linear dose responsesHong-Bin Fang, Douglas D Ross, Edward Sausville, et al.
Journal of Palliative Medicine|October 22, 2005
Long-term evaluation of required coursework in palliative and end-of-life care for medical studentsDouglas D Ross, Deborah Shpritz, Margaret M Hull, et al.
Blood|March 18, 2006
Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expressionTakeo Nakanishi, Ken Shiozawa, Bret A Hassel, et al.
Cancer Chemotherapy and Pharmacology|December 26, 2006
Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPLTamer E Fandy, Douglas D Ross, Steven D Gore, et al.
Molecular Cancer Therapeutics|January 7, 2005
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interferenceP L Rachel Ee, Xiaolong He, Douglas D Ross, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 5, 2003
Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell linesThomas Efferth, Axel Sauerbrey, Marc-Eric Halatsch, et al.
Anticancer Research|January 30, 2003
Activity of ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cellsThomas Efferth, Armin Olbrich, Axel Sauerbrey, et al.
Biochemical Pharmacology|June 1, 2010
Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitorsXuetao Fan, Douglas D Ross, Hiroshi Arakawa, et al.
Neoplasia (New York, N.Y.)|July 20, 2005
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myelomaTamer E Fandy, Sharmila Shankar, Douglas D Ross, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|January 18, 2012
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceKarthika Natarajan, Yi Xie, Maria R Baer, et al.
Statistics in Medicine|January 12, 2008
Experimental design and interaction analysis of combination studies of drugs with log-linear dose responsesHong-Bin Fang, Douglas D Ross, Edward Sausville, et al.
Journal of Palliative Medicine|October 22, 2005
Long-term evaluation of required coursework in palliative and end-of-life care for medical studentsDouglas D Ross, Deborah Shpritz, Margaret M Hull, et al.
Blood|March 18, 2006
Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expressionTakeo Nakanishi, Ken Shiozawa, Bret A Hassel, et al.
Cancer Chemotherapy and Pharmacology|December 26, 2006
Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPLTamer E Fandy, Douglas D Ross, Steven D Gore, et al.
Molecular Cancer Therapeutics|January 7, 2005
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interferenceP L Rachel Ee, Xiaolong He, Douglas D Ross, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 5, 2003
Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell linesThomas Efferth, Axel Sauerbrey, Marc-Eric Halatsch, et al.
Anticancer Research|January 30, 2003
Activity of ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cellsThomas Efferth, Armin Olbrich, Axel Sauerbrey, et al.
Biochemical Pharmacology|June 1, 2010
Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitorsXuetao Fan, Douglas D Ross, Hiroshi Arakawa, et al.
Neoplasia (New York, N.Y.)|July 20, 2005
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myelomaTamer E Fandy, Sharmila Shankar, Douglas D Ross, et al.
Pageof 6